Insider · CIK 0001640436
Mohammad Shahidehpour
Files at WLDN (Willdan Group, Inc.). First filing -, latest -.
Mohammad Shahidehpour files SEC Form 4 as director at WLDN (Willdan Group, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Mohammad Shahidehpour has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 12, 2025 | WLDN Willdan Group, Inc. | 2,273 0.02% of outstanding | $89k | Mar 12, 2025 | none |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2025 | WLDN Willdan Group, Inc. | AGrant or award Common Stock | +1,781 | $0.00 | $0 | 14,548 | Jun 12, 2025 |
Questions about Mohammad Shahidehpour
Answered from the filings on this page, as of the latest one.
Is Mohammad Shahidehpour buying or selling?
Mohammad Shahidehpour has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Mohammad Shahidehpour's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mohammad Shahidehpour has 0.
Where does Mohammad Shahidehpour file Form 4?
Mohammad Shahidehpour has filed Form 4 at WLDN (Willdan Group, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.